Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tanzina Haque"'
Autor:
Nathaniel Lee, Jamie Murphy, Rasheed Al‐Khudairi, Ann Sturdy, Tabitha Mahungu, Tanzina Haque, Paul Griffiths, Jennifer Tosswill, Dianne Irish
Publikováno v:
Transfusion Medicine. 32:256-260
In the United Kingdom, organ donors/recipients are screened for evidence of human T-cell leukaemia virus type-1 and type-2 (HTLV-1/2) infections. Since the United Kingdom is a low prevalence country for HTLV infections, a screening assay with high se
Publikováno v:
Reviews in Medical Virology. 29
Autor:
Gwen Wilkie, Anthony J. Swerdlow, Marie M. Jones, Phoebe Wingate, Deirdre Kelly, Karen A. McAulay, Marc Turner, Alastair MacGilchrist, Dorothy H. Crawford, Craig D. Higgins, Gillian Urquhart, Christopher Bellamy, Tanzina Haque, David J. Burns, P. Amlot, Maher K. Gandhi
Publikováno v:
Blood. 110:1123-1131
We present the results of a multicenter clinical trial using Epstein-Barr virus (EBV)–specific cytotoxic T lymphocytes (CTLs) generated from EBV-seropositive blood donors to treat patients with EBV-positive posttransplantation lymphoproliferative d
Autor:
Gwen Wilkie, Clare Taylor, Anthony J. Swerdlow, Dorothy H. Crawford, Dilani Dombagoda, Parvez Murad, Kate M Britton, Tanzina Haque, Peter Amlot, Angela Iley
Publikováno v:
The Lancet. 360:436-442
Summary Background Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disease (PTLD) is a common, often fatal, complication of bone-marrow and solidorgan transplantation. Since tumour growth results from inadequate T-cell con
Autor:
Tanzina Haque, Dorothy H. Crawford
Publikováno v:
Springer Seminars in Immunopathology. 20:375-387
Epstein-Barr virus (EBV) belongs to the herpesvirus family and shares with other members the characteristic of life-long latency/persistence following primary infection. This persistent infection is controlled by host immune mechanisms such that in t
Autor:
David C. Wheeler, Natasha Old, Suzanne Luck, Colette Smith, Anna Stanton, Paul Sweny, Ruth Kinyanjui, Gareth Jones, Steven Prideaux, Elizabeth Woodford, Mohamed Osman, Sylvie Pichon, Andrew K. Burroughs, Erin McCarrell, James O'Beirne, Sowsan Atabani, Marisa Lanzman, Paul D. Griffiths, M Harber, Douglas Thorburn, Emily Rothwell, David Patch, Claire Atkinson, Richard S. B. Milne, Tanzina Haque, Vincent C. Emery, Andrew Davenport
Publikováno v:
Lancet (London, England). 377(9773)
SummaryBackgroundCytomegalovirus end-organ disease can be prevented by giving ganciclovir when viraemia is detected in allograft recipients. Values of viral load correlate with development of end-organ disease and are moderated by pre-existing natura
Publikováno v:
British Journal of Cancer
McAulay, K A, Haque, T & Crawford, D H 2009, ' Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. ', British Journal of Cancer, vol. 101, no. 6, pp. 1019-1027 . https://doi.org/10.1038/sj.bjc.6605278
McAulay, K A, Haque, T & Crawford, D H 2009, ' Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. ', British Journal of Cancer, vol. 101, no. 6, pp. 1019-1027 . https://doi.org/10.1038/sj.bjc.6605278
BACKGROUND: Epstein-Barr virus-positive post-transplant lymphoproliferative disease (PTLD) is a potentially lethal complication of iatrogenic immunosupression after transplantation. Predicting the development of PTLD allowing early and effective inte
Publikováno v:
Transplantation. 90:93-94